Gene Set Cancer Analysis revealed that the overexpression of the BRAF/MEK/PI3K oncogenic signature in CRC directly correlates with the recruitment of pro-tumor immune cells into the TME (https://guolab.wchscu.cn/GSCA/#/) accessed on 24 June 2025 (Figure 8). The gene discussed is BRAF; the disease is colorectal carcinoma.